Journal of affective disorders · 2024
An empirical analysis of structural neuroimaging profiles in a staging model of depression.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nogovitsyn Nikita, Ballester Pedro, Lasby Mike, Dunlop Katharine, Ceniti Amanda K, Squires Scott, Rowe Jessie, Ho Keith, Suh JeeSu, Hassel Stefanie, Souza Roberto, Casseb Raphael F, Harris Jacqueline K, Zamyadi Mojdeh, Arnott Stephen R, Strother Stephen C, Hall Geoffrey, Lam Raymond W, Poppenk Jordan, Lebel Catherine, Bray Signe, Metzak Paul, MacIntosh Bradley J, Goldstein Benjamin I, Wang JianLi, Rizvi Sakina J, MacQueen Glenda, Addington Jean, Harkness Kate L, Rotzinger Susan, Kennedy Sidney H, Frey Benicio N
Аннотация
We examine structural brain characteristics across three diagnostic categories: at risk for serious mental illness; first-presenting episode and recurrent major depressive disorder (MDD). We investigate whether the three diagnostic groups display a stepwise pattern of brain changes in the cortico-limbic regions. Integrated clinical and neuroimaging data from three large Canadian studies were pooled (total n = 622 participants, aged 12-66 years). Four clinical profiles were used in the classification of a clinical staging model: healthy comparison individuals with no history of depression (HC, n = 240), individuals at high risk for serious mental illness due to the presence of subclinical symptoms (SC, n = 80), first-episode depression (FD, n = 82), and participants with recurrent MDD in a current major depressive episode (RD, n = 220). Whole-brain volumetric measurements were extracted with FreeSurfer 7.1 and examined using three different types of analyses. Hippocampal volume decrease and cortico-limbic thinning were the most informative features for the RD vs HC comparisons. FD vs HC revealed that FD participants were characterized by a focal decrease in cortical thickness and global enlargement in amygdala volumes. Greater total amygdala volumes were significantly associated with earlier onset of illness in the FD but not the RD group. We did not confirm the construct validity of a tested clinical staging model, as a differential pattern of brain alterations was identified across the three diagnostic groups that did not parallel a stepwise clinical staging approach. The pathological processes during early stages of the illness may fundamentally differ from those that occur at later stages with clinical progression.